Literature DB >> 17576578

Evolution of the restorative proctocolectomy and its effects on gastrointestinal hormones.

Amosy E M'Koma1, Paul E Wise, Roberta L Muldoon, David A Schwartz, Mary K Washington, Alan J Herline.   

Abstract

Gastrointestinal (GI) peptide hormones are chemical messengers that regulate secretory, mechanical, metabolic, and trophic functions of the gut. Restorative proctocolectomy (RPC) or resection of the colon and rectum with maintenance of intestinal continuity through the construction of an ileal pouch reservoir and preservation of the anal sphincters has become the standard of care for the surgical treatment of ulcerative colitis and familial adenomatous polyposis. The manipulation of the digestive system to create the ileal pouch involves altering gut-associated lymphoid tissue among other anatomic changes that lead to changes in GI peptides. In addition, the ileal pouch epithelium responds to a wide variety of stimuli by adjusting its cellularity and function. These adaptive mechanisms involve systemic factors, such as humoral and neural stimuli, as well as local factors, such as changes in intestinal peristalsis and intraluminal nutrients. There have been conflicting reports as to whether the alterations in GI hormones after RPC have actual clinical implications. What the studies on alterations of GI peptides' response and behavior after RPC have contributed, however, is a window into the possible etiology of complications after pouch surgery, such as pouchitis and malabsorption. Given the possibility of pharmacologically modifying GI peptides or select components of adaptation as a therapeutic strategy for patients with ileal pouch dysfunction or pouchitis, a clear understanding of human pouch mucosal adaptation is of paramount importance. In this review, we summarize the evolution of the RPC and its effects on the GI hormones as well as their possible clinical implications.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17576578     DOI: 10.1007/s00384-007-0331-x

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  233 in total

Review 1.  What functional outcomes and complications should be taught to the patient with ulcerative colitis or familial adenomatous polyposis who undergoes ileal pouch anal anastomosis?

Authors:  J C Colwell; M Gray
Journal:  J Wound Ostomy Continence Nurs       Date:  2001-07       Impact factor: 1.741

2.  Functional outcome and quality of life in an elderly patient with an ileal pouch-anal anastomosis: a 10-year follow up.

Authors:  J M Church
Journal:  Aust N Z J Surg       Date:  2000-12

3.  Elimination of mucosectomy during restorative proctocolectomy in patients with ulcerative colitis may provide better results in low-volume centers.

Authors:  Cuneyt Kayaalp; Gurel Nessar; Musa Akoglu; Fuat Atalay
Journal:  Am J Surg       Date:  2003-03       Impact factor: 2.565

4.  THE CONSTITUTION AND PROPERTIES OF TWO GASTRINS EXTRACTED FROM HOG ANTRAL MUCOSA.

Authors:  R A GREGORY; H J TRACY
Journal:  Gut       Date:  1964-04       Impact factor: 23.059

5.  Regulation of gastric function by intrahypothalamic galanin.

Authors:  J S Davison; C L Mah
Journal:  Proc West Pharmacol Soc       Date:  1997

6.  The further purification of motilin, a gastric motor activity stimulating polypeptide from the mucosa of the small intestine of hogs.

Authors:  J C Brown; V Mutt; J R Dryburgh
Journal:  Can J Physiol Pharmacol       Date:  1971-05       Impact factor: 2.273

7.  Equivalent function, quality of life and pouch survival rates after ileal pouch-anal anastomosis for indeterminate and ulcerative colitis.

Authors:  Conor P Delaney; Feza H Remzi; Terry Gramlich; Babak Dadvand; Victor W Fazio
Journal:  Ann Surg       Date:  2002-07       Impact factor: 12.969

8.  Vipoma of the pancreas complicating ulcerative colitis.

Authors:  H Yanagi; M Kusunoki; Y Sakanoue; Y Shoji; T Yamamura; M Murai; N Kikkawa; J Utsunomiya
Journal:  Am J Gastroenterol       Date:  1991-08       Impact factor: 10.864

9.  Ileal pouch-anal anastomosis for ulcerative colitis and polyposis coli: is the risk of carcinoma formation conclusively averted?

Authors:  G D Giebel; H Sabiers
Journal:  Eur J Surg Oncol       Date:  1996-08       Impact factor: 4.424

10.  Release of motilin by oral and intravenous nutrients in man.

Authors:  N D Christofides; S R Bloom; H S Besterman; T E Adrian; M A Ghatei
Journal:  Gut       Date:  1979-02       Impact factor: 23.059

View more
  11 in total

Review 1.  Pouch-related dysplasia and adenocarcinoma following restorative proctocolectomy for ulcerative colitis.

Authors:  J W Um; A E M'Koma
Journal:  Tech Coloproctol       Date:  2011-02-02       Impact factor: 3.781

Review 2.  Inflammatory bowel disease-associated colorectal cancer: proctocolectomy and mucosectomy do not necessarily eliminate pouch-related cancer incidences.

Authors:  Amosy E M'Koma; Harold L Moses; Samuel E Adunyah
Journal:  Int J Colorectal Dis       Date:  2011-02-11       Impact factor: 2.571

3.  Subsequent Adenomas of Ileal Pouch and Anorectal Segment after Prophylactic Surgery for Familial Adenomatous Polyposis.

Authors:  A E M'Koma; A J Herline; S E Adunyah
Journal:  World J Colorectal Surg       Date:  2013

Review 4.  Diagnosis of inflammatory bowel disease: Potential role of molecular biometrics.

Authors:  Amosy E M'Koma
Journal:  World J Gastrointest Surg       Date:  2014-11-27

Review 5.  Inflammatory Bowel Disease: Clinical Diagnosis and Surgical Treatment-Overview.

Authors:  Amosy Ephreim M'Koma
Journal:  Medicina (Kaunas)       Date:  2022-04-21       Impact factor: 2.948

Review 6.  Prevalence and outcome of anemia after restorative proctocolectomy: a clinical literature review.

Authors:  Amosy E M'Koma; Paul E Wise; David A Schwartz; Roberta L Muldoon; Alan J Herline
Journal:  Dis Colon Rectum       Date:  2009-04       Impact factor: 4.585

7.  Adenocarcinomas After Prophylactic Surgery For Familial Adenomatous Polyposis.

Authors:  Joan C Smith; Michael W Schäffer; Billy R Ballard; Duane T Smoot; Alan J Herline; Samuel E Adunyah; Amosy E M'Koma
Journal:  J Cancer Ther       Date:  2013

8.  Characterization of Serum Cytokine Profile in Predominantly Colonic Inflammatory Bowel Disease to Delineate Ulcerative and Crohn's Colitides.

Authors:  Olga Y Korolkova; Jeremy N Myers; Samuel T Pellom; Li Wang; Amosy E M'Koma
Journal:  Clin Med Insights Gastroenterol       Date:  2015-05-06

9.  Adaptive Returns of Deficient Systemic Plasma Immunoglobulin G Levels as Rehabilitation Biomarker After Emergency Colectomy for Fulminant Ulcerative Colitis.

Authors:  Alexander T Hawkins; Jun W Um; Amosy E M'Koma
Journal:  Clin Med Insights Gastroenterol       Date:  2017-12-13

Review 10.  Inflammatory bowel disease: an expanding global health problem.

Authors:  Amosy E M'Koma
Journal:  Clin Med Insights Gastroenterol       Date:  2013-08-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.